The global pharmacovigilance market is expected to be worth USD 12.48 Billion by 2027, according to a current analysis by Emergen Research. The market for pharmacovigilance is experiencing rapid growth attributed to a rise in application for spontaneous reporting, electronic health record (HER) mining, cohort event monitoring, and intensified adverse drug reaction (ADR) reporting, among others. The pharmacovigilance primarily emphasizes on on ADR (adverse drug reactions) and cases of drug toxicity. According to the statistic released by WHO, about 5.0% of hospitalized patients in the developed nations are admitted into the hospital due to adverse drug reactions, and 6.0% to 10% of in-patients are anticipated to observe a severe adverse reaction for the duration of hospitalization.The rising prevalence of women’s chronic health disorder is one of the significant factors influencing the market growth.
The latest research report serves as a perfect example of the precise analysis of the global Women’s Health market. It includes the ToC, list of tables and figures, research methodology, geographic segmentation, competitive landscape, future developments, and technological innovation. Moreover, the report offers the latest coverage of the massive impact of the COVID-19 pandemic on the worldwide Women’s Health industry. The globally-disrupting incidence has impacted nearly every aspect of this business domain. However, the latest study expounds on the present market scenario and forecasts the pandemic’s aftermath, with respect to this industry. Furthermore, the major aspects of the market have been discussed in the report, with expert opinions on the current status of the market.
Key participants include Merck Co., Allergan, Bayer AG, Novartis AG, Pfizer, Amgen, Lupin Limited, Johnson Johnson Services Inc., Agile Therapeutics, and Apothecus Pharmaceutical Corporation, among others.
Get a sample of the report : https://www.emergenresearch.com/request-sample/91
The current COVID-19 pandemic is expected to have an effect on the growth of the Women’s Health industry majorly attributable to the movement restrictions and impact on the supply and demand due to the lockdowns. The COVID-19 pandemic has affected several sectors of the global market, and the Women’s Health sector is expected to feel the impact of the pandemic. The economic slowdown and dynamic changes in the demands will further affect the growth of the industry. The report covers the impact analysis of the COVID-19 pandemic on the overall Women’s Health industry.Use of female contraception is beneficial in the prevention of health issues associated with pregnancy, particularly for pubescent girls, as well as in pregnancy planning to reduce the chances of infant mortality, which is higher in childbirths separated by a lesser number of years.
Market Scope:
One of the report’s central components is the broad Women’s Health market segmentation that includes the product type gamut, application spectrum, end-user industry landscape, significant geographical regions, and the top market contenders. The key players’ financial positions, along with their gross profits, sales volumes, sales revenue, manufacturing costs, and other financial ratios, have been accurately gauged in the report. Furthermore, several analytical tools like investment assessment, SWOT analysis, and Porter’s Five Forces Analysis have been implemented by our analysts’ team to evaluate the production and distribution capacities of the Women’s Health market players.
By product type, devices held a substantial women’s health market share in 2019. The introduction of minimally invasive methods has escalated the demand for several surgical procedures amid the women population. Also, a growing trend among female patients’ towards technologically advanced techniques for treatment is the causative of market growth. Besides, it provides various other prospective benefits comprising prolonged prospects for education and women empowerment, along with maintaining a healthy population and economic growth of nations
By application, hormonal infertility is projected to grow at the fastest rate of 13.6% in the forecast period. High levels of FSH (follicle-stimulating hormone) in female blood may decrease the chances of conceiving. Also, abnormal estradiol, a kind of estrogen hormone, levels may reduce the possibility of success in vitro fertilization (IVF).
The report clearly defines the Women’s Health market position on a global level. The detailed insights into the market’s geographical spectrum offered by the report make it an excellent source of knowledge about the Women’s Health industry.
Emergen Research has segmented the global women’s health market on the basis of product type, application, end-users, and region:
Product Type Outlook (Revenue, USD Billion; 2017-2027)
- Devices
- Drugs
Application Outlook (Revenue, USD Billion; 2017-2027)
- Contraceptives
- Postmenopausal Osteoporosis
- Hormonal Infertility
- Menopause
- Endometriosis
- Polycystic Ovary Syndrome (PCOS)
- Others
Request a discount on the report : https://www.emergenresearch.com/request-discount/91
End Users Outlook (Revenue, USD Billion; 2017-2027)
- Hospitals Clinics
- Obstetrics Gynecology Centers
- Ambulatory Surgical Centers
- Research Institutes
- Others
TOC of the global Women’s Health market report:
Chapter 1, describes the Women’s Health Introduction, market overview, product offerings, growth opportunities, market risks, driving forces, and challenges.
Chapter 2, analyzes the key manufacturers of Women’s Health , along with the sales, revenue, and price of Women’s Health , in the forecast period.
Chapter 3, studies the competitive situation among the major manufacturers and vendors, with sales, revenue, and market share.
Chapter 4, analyzes the global market by regions, with sales, revenue, and market share of Women’s Health , for each region, from 2020 to 2027.
Chapters 5, 6, 7, 8 and 9, analyze the Women’s Health market by type, application, regions, and manufacturers, with sales, revenue, and market share by key countries in these regions…Continued
Key Points of Women’s Health Market:
Extensive coverage of the analysis of the Women’s Health market
Key insights into the regional spread of the industry in key geographies
Radical insights into the vital market trends; both current and emerging trends, and factors influencing the growth of the market
Comprehensive coverage of the impact of the COVID-19 pandemic on the overall growth of the Women’s Health market
Complete data about the key manufacturers and vendors in the Women’s Health market
Read More: https://www.emergenresearch.com/industry-report/womens-health-market
Related Reports:
Patient Engagement Solutions Market: https://www.emergenresearch.com/industry-report/patient-engagement-solutions-market
Nucleic Acid Isolation and Purification Market: https://www.emergenresearch.com/industry-report/nucleic-acid-isolation-and-purification-market
Non-Invasive Prenatal Testing Market: https://www.emergenresearch.com/industry-report/non-invasive-prenatal-testing-market
Medical Radiation Detection, Monitoring, and Safety Market: https://www.emergenresearch.com/industry-report/in-vitro-fertilization-market
Blockchain in Healthcare: Https://www.forbes.com/sites/forbestechcouncil/2021/12/07/four-key-medtech-software-development-trends-for-2022/?sh=23e843f420d5
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]
Facebook | LinkdIn | Twitter | Blogs
